N-Terminal Acetylation, And Reading It On A Name
N-terminal acetylation is the replacement of one hydrogen on the alpha-amino group at the start of a sequence with an acetyl group, CH3CO. The modification adds a monoisotopic mass of 42.0106 Da and an average mass of 42.037 Da, and it removes the positive charge that the free terminal amine would otherwise carry near neutral pH. On a product name it is written as the prefix Ac-, and reading that prefix correctly is the difference between two molecules with different masses, different retention and different chromatograms.
A synthetic peptide leaves the resin with a free alpha-amino group at the N terminus unless something was done to cap it. Acetylation is the simplest cap available: acetic anhydride, or acetylimidazole, reacts with that amine while the chain is still attached to the resin, and the resulting amide bond survives the acid cleavage step that removes the side-chain protecting groups.
The structural consequence is narrow and precise. One hydrogen is gone, an acetyl group is in its place, and the terminal nitrogen now sits in an amide rather than in a primary amine. An amide nitrogen does not accept a proton at physiological pH, so the molecule carries one fewer positive charge than the uncapped sequence. Everything downstream, the isoelectric point, the charge-state distribution in a mass spectrum, the retention on a reverse-phase column, follows from that single change.
The other reason the modification is common is that the free alpha-amino group is the entry point for several degradation routes. Capping it closes off N-terminal aminopeptidase cleavage in biological matrices and removes the nucleophile that drives certain intramolecular rearrangements. Whether that matters for any given sequence is a question about that sequence, and this article makes no claim about it.
The mass arithmetic, and the trap inside it
| Modification | Formula added | Monoisotopic shift (Da) |
|---|---|---|
| Acetylation | C2H2O | +42.0106 |
| Trimethylation | C3H6 (three methyls, one H lost) | +42.0470 |
| Carbamylation | CHNO | +43.0058 |
| Formylation | CO | +27.9949 |
| Difference, acetyl versus trimethyl | - | 0.0364 |
That 0.0364 Da gap is the whole problem. At a precursor mass to charge ratio of 1000 the two shifts differ by roughly 36 parts per million, which a time-of-flight instrument at 10,000 resolving power will not separate as two peaks. Distinguishing them requires either high resolving power, on the order of 30,000 or better at that mass, or fragmentation evidence that places the shift on the terminal residue.
Average mass and monoisotopic mass also part company here, and the gap widens with molecular size. A calculated value quoted without saying which convention it uses is not a checkable number.
Reading it off a name
Naming conventions for the modification are stable. The prefix Ac- before the sequence, as in Ac-SDKP, means the N terminus is acetylated. Written in full it appears as N-acetyl or N-alpha-acetyl. The three-letter form is sometimes written Ac-Ser-Asp-Lys-Pro-OH, where the trailing -OH states that the C terminus is a free acid rather than an amide.
- Ac- prefix: N-terminal acetyl cap, mass +42.0106 Da monoisotopic.
- -NH2 suffix: C-terminal amide, a separate modification at the other end of the chain with a shift of -0.9840 Da against the free acid.
- No prefix: free alpha-amino group, one additional positive charge near neutral pH.
- Acetate in the salt name: a counterion, not a covalent modification, and not visible as a mass shift on the peptide ion.
The last line is the one most often confused. An acetate salt form has acetic acid present as a counterion paired with basic side chains, contributing to the weighed mass of the powder while sitting entirely outside the covalent structure. Acetylation is a bond. The two words share a root and describe unrelated things.
What it does to a chromatogram
Removing a positive charge and adding a small hydrophobic group both push retention later on a reverse-phase column. In a 0.1 percent trifluoroacetic acid and acetonitrile gradient the acetylated form typically elutes after the free-amine form, often by a fraction of a minute to a couple of minutes depending on gradient slope and sequence length. For a short sequence the two can be fully resolved; for a long one the shift may be small enough that the peaks overlap.
At 214 nm the acetyl group adds an amide bond to the count, so its extinction contribution is small but not zero. At 280 nm it contributes nothing, because the group carries no aromatic system. A concentration figure calculated from absorbance at 280 nm using a sequence-derived extinction coefficient is therefore unaffected by the cap, while area percent at 214 nm shifts slightly.
The failure mode: incomplete capping
The specific thing that goes wrong is a partial reaction. Acetylation of the resin-bound chain is fast, but a sterically hindered N terminus, an aggregated chain, or a reagent excess that was too low leaves a fraction of the material uncapped. The lot then contains two species: the intended acetylated sequence and the free-amine sequence, 42 Da lighter.
It shows up as a pair of peaks in a fixed ratio across repeat runs, with the earlier peak 42 Da lighter by mass, and it survives purification poorly because the two forms can be close in retention. The reverse case also occurs: unintended acetylation of a lysine side-chain amine during the capping step, which produces material 42 Da heavier than intended at a position nobody specified. Both are mass-visible and neither is visible on appearance.
What Aurum states, and what it does not
We list a sequence and, where the item is acetylated, the Ac- prefix forms part of the name as supplied. Our published purity figures are reverse-phase HPLC area percent at 214 nm, and our mass confirmation is a mass to charge ratio consistent with the stated molecular formula. High-resolution accurate-mass work capable of separating a +42 is not among the specifications Aurum publishes.0106 Da acetyl shift from a +42.0470 Da trimethyl shift, and Fragmentation analysis to localise a modification to a named residue is not among the specifications Aurum publishes. Where a project depends on the position of the cap being confirmed rather than stated, that confirmation has to come from a laboratory that runs the method.
Common questions
Does acetylation change the molecular formula on a label?
Yes. Two carbons, two hydrogens and one oxygen are added to the formula, and any calculated mass on the label should reflect that. A formula that matches the uncapped sequence next to a name carrying the Ac- prefix is an internal contradiction worth querying.
Is N-terminal acetylation the same as C-terminal amidation?
No. C-terminal amidation sits at the opposite end of the chain and carries a different mass shift, -0.9840 Da against +42.0106 Da. A sequence can carry both, one, or neither.
Can acetylation be removed?
Not selectively under ordinary conditions. The bond is a stable amide, and conditions strong enough to hydrolyse it also cleave the backbone.
Why does an acetylated peptide sometimes look less soluble in water?
Because the modification removes one charged group and adds a small non-polar one, both of which lower net charge and raise hydrophobicity. The direction is predictable; the magnitude depends on the rest of the sequence.
References
- 01United States Pharmacopeia General Chapter <1055> Biotechnology-Derived Articles - Peptide Mapping. USP-NF.
- 02United States Pharmacopeia General Chapter <736> Mass Spectrometry. USP-NF.
- 03European Directorate for the Quality of Medicines General Chapter 2.2.43: Mass Spectrometry. European Pharmacopoeia.
- 04International Union of Pure and Applied Chemistry Nomenclature and Symbolism for Amino Acids and Peptides: Recommendations 1983. IUPAC-IUB Joint Commission on Biochemical Nomenclature.
- 05International Council for Harmonisation Q6A: Specifications - Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. ICH, 1999.
- 06Merrifield RB Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society, 1963.
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.